QIM
Quantitative Investment Management’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-5,642
| Closed | -$650K | – | 430 |
|
|
2024
Q3 | $650K | Buy |
+5,642
| New | +$650K | 0.06% | 214 |
|
|
2023
Q1 | – | Sell |
-4,604
| Closed | -$549K | – | 295 |
|
|
2022
Q4 | $549K | Buy |
+4,604
| New | +$549K | 0.1% | 139 |
|
|
2021
Q4 | – | Sell |
-13,377
| Closed | -$1.28M | – | 386 |
|
|
2021
Q3 | $1.28M | Buy |
+13,377
| New | +$1.28M | 0.12% | 172 |
|
|
2020
Q1 | – | Sell |
-51,628
| Closed | -$5.55M | – | 727 |
|
|
2019
Q4 | $5.55M | Buy |
51,628
+11,055
| +27% | +$1.19M | 0.17% | 147 |
|
|
2019
Q3 | $3.66M | Buy |
+40,573
| New | +$3.66M | 0.2% | 149 |
|
|
2019
Q2 | – | Sell |
-2,700
| Closed | -$237K | – | 765 |
|
|
2019
Q1 | $237K | Sell |
2,700
-29,400
| -92% | -$2.58M | 0.01% | 589 |
|
|
2018
Q4 | $2.29M | Buy |
+32,100
| New | +$2.29M | 0.12% | 164 |
|
|
2018
Q3 | – | Sell |
-31,700
| Closed | -$3.11M | – | 795 |
|
|
2018
Q2 | $3.11M | Buy |
+31,700
| New | +$3.11M | 0.06% | 284 |
|
|
2018
Q1 | – | Sell |
-41,700
| Closed | -$3.24M | – | 867 |
|
|
2017
Q4 | $3.24M | Sell |
41,700
-25,800
| -38% | -$2M | 0.05% | 402 |
|
|
2017
Q3 | $4.14M | Buy |
+67,500
| New | +$4.14M | 0.05% | 370 |
|
|
2016
Q3 | – | Sell |
-16,600
| Closed | -$754K | – | 802 |
|
|
2016
Q2 | $754K | Buy |
16,600
+2,500
| +18% | +$114K | 0.04% | 480 |
|
|
2016
Q1 | $557K | Buy |
14,100
+8,600
| +156% | +$340K | 0.03% | 527 |
|
|
2015
Q4 | $311K | Sell |
5,500
-33,500
| -86% | -$1.89M | 0.02% | 581 |
|
|
2015
Q3 | $1.55M | Buy |
39,000
+31,100
| +394% | +$1.24M | 0.12% | 219 |
|
|
2015
Q2 | $377K | Buy |
+7,900
| New | +$377K | 0.06% | 288 |
|